Showing results (601-610 of 785) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 3, 2025
The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJack Stone, Kennedy Kipkoech Mutai, Adelina Artenie, et al.
The Lancet. HIV|December 28, 2020
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort studyColette Smit, Anders Boyd, Bart J A Rijnders, et al.
The Lancet. HIV|December 10, 2019
Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programmeJohn Kinuthia, Jillian Pintye, Felix Abuna, et al.
The Lancet. HIV|April 3, 2020
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trialKelly E Dooley, Radojkam Savic, Akshay Gupte, et al.
The Lancet. HIV|October 3, 2020
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in CameroonAlexandra Calmy, Tamara Tovar Sanchez, Charles Kouanfack, et al.
The Lancet. HIV|July 31, 2021
Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional studyEshan U Patel, Sunil S Solomon, Gregory M Lucas, et al.
The Lancet. HIV|June 6, 2022
Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regressionSamira Hosseini-Hooshyar, Behzad Hajarizadeh, Sahar Bajis, et al.
The Lancet. HIV|June 24, 2022
Integrating HIV and mental health interventions to address a global syndemic among men who have sex with menDon Operario, Shufang Sun, Amiel Nazer Bermudez, et al.
The Lancet. HIV|December 14, 2020
Primary HIV-1 infection in users of pre-exposure prophylaxisJuan Ambrosioni, Elisa Petit, Geoffroy Liegeon, et al.
The Lancet. HIV|February 5, 2022
Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gapsAnushka Naidoo, Kogieleum Naidoo, Nesri Padayatchi, et al.
Pageof 79